Get started
KODEX GLOBAL OBESITY TREATMENT TOP2 PLUSKODEX GLOBAL OBESITY TREATMENT TOP2 PLUSKODEX GLOBAL OBESITY TREATMENT TOP2 PLUS

KODEX GLOBAL OBESITY TREATMENT TOP2 PLUS

No trades
See on Supercharts
Overview Analysis
Holdings
Discussions Technicals Seasonals

KODEX GLOBAL OBESITY TREATMENT TOP2 PLUS holdings


As of April 30, 2025
Symbol
Weight %
Shares
Shares Chg %
1M
Market value
Market value Chg %
1M
L
LLYEli Lilly and Company
26.78%
‪‪13.44 K‬‬
+92.74%
‪‪17.17 B‬‬KRW
+102.52%
N
NVONovo Nordisk A/S Sponsored ADR Class B
20.52%
‪‪139.33 K‬‬
+91.51%
‪‪13.16 B‬‬KRW
+76.92%
R
RYTMRhythm Pharmaceuticals, Inc.
8.44%
‪‪58.43 K‬‬
+88.49%
‪‪5.41 B‬‬KRW
+123.94%
V
VKTXViking Therapeutics, Inc.
6.85%
‪‪107.09 K‬‬
+77.60%
‪‪4.39 B‬‬KRW
+104.96%
R
ROGRoche Holding Ltd Dividend Right Cert.
6.57%
‪‪9.05 K‬‬
+88.96%
‪‪4.22 B‬‬KRW
+82.06%
A
AZNAstraZeneca PLC Sponsored ADR
6.40%
‪‪40.19 K‬‬
+93.93%
‪‪4.10 B‬‬KRW
+82.86%
A
AMGNAmgen Inc.
6.37%
‪‪9.88 K‬‬
+96.24%
‪‪4.08 B‬‬KRW
+76.90%
Z
ZEALZealand Pharma A/S
5.91%
‪‪37.96 K‬‬
+78.66%
‪‪3.79 B‬‬KRW
+62.00%
M
MTSRMetsera, Inc.
5.84%
‪‪109.27 K‬‬
+83.12%
‪‪3.74 B‬‬KRW
+56.58%
R
REGNRegeneron Pharmaceuticals, Inc.
5.80%
‪‪4.37 K‬‬
+84.31%
‪‪3.72 B‬‬KRW
+67.98%
Get deeper insights with ETF data
Explore detailed ETF holdings data, including weight, shares, and market value.